This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Modernatx, Inc.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Ciarán Lawlor: Innovator in Nucleic Acid Compositions
Introduction
Ciarán Lawlor is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the formulation and delivery of modified nucleic acid compositions. His work has the potential to impact various applications in medicine and genetic engineering.
Latest Patents
Ciarán Lawlor holds a patent for the "Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions." This patent describes formulation compositions that include modified nucleic acid molecules capable of encoding proteins or protein precursors. The invention also encompasses delivery agents that enhance the effectiveness of these formulations. The nucleic acids developed through this work are designed to modulate cellular functions and activities.
Career Highlights
Ciarán Lawlor is associated with Modernatx, Inc., a company known for its innovative approaches in the biotechnology sector. His expertise in nucleic acid formulations has positioned him as a key player in the development of advanced therapeutic solutions.
Collaborations
Ciarán has collaborated with notable colleagues such as Antonin De Fougerolles and Stephen G Hoge. These partnerships have fostered a collaborative environment that enhances the research and development of cutting-edge biotechnological solutions.
Conclusion
Ciarán Lawlor's contributions to the field of modified nucleic acid compositions exemplify the innovative spirit of modern biotechnology. His work continues to pave the way for advancements in therapeutic applications and cellular modulation.